192 related articles for article (PubMed ID: 27981892)
21. CRM1 and BRAF inhibition synergize and induce tumor regression in BRAF-mutant melanoma.
Salas Fragomeni RA; Chung HW; Landesman Y; Senapedis W; Saint-Martin JR; Tsao H; Flaherty KT; Shacham S; Kauffman M; Cusack JC
Mol Cancer Ther; 2013 Jul; 12(7):1171-9. PubMed ID: 23615632
[TBL] [Abstract][Full Text] [Related]
22. Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m
Zhang QC; Qian YM; Ren YH; Chen MM; Cao LM; Zheng SJ; Li BB; Wang M; Wu X; Xu K
Acta Pharmacol Sin; 2024 Mar; 45(3):619-632. PubMed ID: 37848553
[TBL] [Abstract][Full Text] [Related]
23. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
Meissner T; Krause E; Vinkemeier U
FEBS Lett; 2004 Oct; 576(1-2):27-30. PubMed ID: 15474004
[TBL] [Abstract][Full Text] [Related]
24. Phenethyl isothiocyanate potentiates anti-tumour effect of doxorubicin through Akt-dependent pathway.
Eisa NH; ElSherbiny NM; Shebl AM; Eissa LA; El-Shishtawy MM
Cell Biochem Funct; 2015 Dec; 33(8):541-51. PubMed ID: 26548747
[TBL] [Abstract][Full Text] [Related]
25. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export.
Strunze S; Trotman LC; Boucke K; Greber UF
Mol Biol Cell; 2005 Jun; 16(6):2999-3009. PubMed ID: 15814838
[TBL] [Abstract][Full Text] [Related]
26. Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation.
Satyan KS; Swamy N; Dizon DS; Singh R; Granai CO; Brard L
Gynecol Oncol; 2006 Oct; 103(1):261-70. PubMed ID: 16624391
[TBL] [Abstract][Full Text] [Related]
27. XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.
Cheng Y; Holloway MP; Nguyen K; McCauley D; Landesman Y; Kauffman MG; Shacham S; Altura RA
Mol Cancer Ther; 2014 Mar; 13(3):675-86. PubMed ID: 24431073
[TBL] [Abstract][Full Text] [Related]
28. Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.
Zhang K; Wang M; Tamayo AT; Shacham S; Kauffman M; Lee J; Zhang L; Ou Z; Li C; Sun L; Ford RJ; Pham LV
Exp Hematol; 2013 Jan; 41(1):67-78.e4. PubMed ID: 22986101
[TBL] [Abstract][Full Text] [Related]
29. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.
Ishizawa J; Kojima K; Hail N; Tabe Y; Andreeff M
Pharmacol Ther; 2015 Sep; 153():25-35. PubMed ID: 26048327
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Chen Y; Camacho SC; Silvers TR; Razak AR; Gabrail NY; Gerecitano JF; Kalir E; Pereira E; Evans BR; Ramus SJ; Huang F; Priedigkeit N; Rodriguez E; Donovan M; Khan F; Kalir T; Sebra R; Uzilov A; Chen R; Sinha R; Halpert R; Billaud JN; Shacham S; McCauley D; Landesman Y; Rashal T; Kauffman M; Mirza MR; Mau-Sørensen M; Dottino P; Martignetti JA
Clin Cancer Res; 2017 Mar; 23(6):1552-1563. PubMed ID: 27649553
[No Abstract] [Full Text] [Related]
31. Leptomycin B alters the subcellular distribution of CRM1 (Exportin 1).
Rahmani K; Dean DA
Biochem Biophys Res Commun; 2017 Jun; 488(2):253-258. PubMed ID: 28412356
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
Schütz SV; Cronauer MV; Rinnab L
J Cell Biochem; 2010 Apr; 109(6):1192-200. PubMed ID: 20127713
[TBL] [Abstract][Full Text] [Related]
33. Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model.
Gupta P; Adkins C; Lockman P; Srivastava SK
PLoS One; 2013; 8(6):e67278. PubMed ID: 23826254
[TBL] [Abstract][Full Text] [Related]
34. Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.
Arend RC; Londoño-Joshi AI; Gangrade A; Katre AA; Kurpad C; Li Y; Samant RS; Li PK; Landen CN; Yang ES; Hidalgo B; Alvarez RD; Straughn JM; Forero A; Buchsbaum DJ
Oncotarget; 2016 Dec; 7(52):86803-86815. PubMed ID: 27888804
[TBL] [Abstract][Full Text] [Related]
35. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
36. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
Xiao D; Singh SV
Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
[TBL] [Abstract][Full Text] [Related]
37. The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway.
Fleta-Soriano E; Martinez JP; Hinkelmann B; Gerth K; Washausen P; Diez J; Frank R; Sasse F; Meyerhans A
Microb Cell Fact; 2014 Jan; 13():17. PubMed ID: 24475978
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
Chutiwitoonchai N; Mano T; Kakisaka M; Sato H; Kondoh Y; Osada H; Kotani O; Yokoyama M; Sato H; Aida Y
Virology; 2017 Jul; 507():32-39. PubMed ID: 28399435
[TBL] [Abstract][Full Text] [Related]
39. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K
Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321
[TBL] [Abstract][Full Text] [Related]
40. The nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates NFkappaB activation in Drosophila.
Xylourgidis N; Roth P; Sabri N; Tsarouhas V; Samakovlis C
J Cell Sci; 2006 Nov; 119(Pt 21):4409-19. PubMed ID: 17032737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
